Evidence map›Paper›PMID 41735913›Full record

ArticleBMC geriatrics2026

Body mass index-based inflammation index is a promising prognostic predictor in older adult cancer patients.

Jia-Xin Huang, Xi Zhang, Min Yang, Meng Tang, Qi Zhang, Li Deng, Chun-Hua Song, Wei Li, Han-Ping Shi, Ming-Hua Cong

Abstract readMulticenter Study
In one paragraph

Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jia-Xin Huang *Comprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xi Zhang *Comprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Min Yang *Comprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Meng TangComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Qi ZhangKey Laboratory of Cancer, FSMP for State Market Regulation, Beijing, China.
Li DengKey Laboratory of Cancer, FSMP for State Market Regulation, Beijing, China.
Chun-Hua SongDepartment of Epidemiology, College of Public Health, Zhengzhou University, Zheng zhou, China.
Wei LiCancer Center of the First Hospital of Jilin University, Changchun, 130021, People's Republic of China.
Han-Ping ShiKey Laboratory of Cancer, FSMP for State Market Regulation, Beijing, China. shihp@ccmu.edu.cn.
Ming-Hua CongComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. congmh@cicams.ac.cn.

Funding

National Multidisciplinary Cooperative Diagnosis and Treatment Capacity Project for Major Diseases: Comprehensive Treatment and Management of Critically Ill Elderly Inpatients No. 2019.YLFW
6 · The paper itself

Abstract

backgroundOlder patients with cancer often have a worse prognosis than the general cancer patient population due to decreased immune responses, chronic inflammation status, and malnutrition. The present study aimed to develop a novel body mass index (BMI)-based inflammation index and investigate its prognostic significance in older patients with cancer.

methodsThis multicenter prospective study totally included 2376 cancer patients aged 65 years or older. Concordance index (C-index) and receiver operating characteristic (ROC) curves were applied to compare the prognostic value of various BMI-based inflammation indices. The overall survival (OS) was calculated and compared using the Kaplan–Meier method generated by the log-rank test. A Cox proportional hazard regression model was performed to identify independent predictors associated with OS. Subgroup analysis was used to explore the discriminative performance in different populations. The second outcomes included short-term survival, malnutrition and cachexia.

resultsWe recorded 1112 death cases during a median follow-up of 17.43 months. Both the area under ROC curves and the C-index of the BMI to C-reactive protein/lymphocyte ratio (BCLR) were higher than other inflammation indices. There was a significant L-shaped association between BCLR and all-cause mortality in older patients with cancer (P < 0.001). A low BCLR was significantly associated with shortened OS and served as an independent risk factor for survival in older patients with cancer (hazard ratio = 1.51, 95% confidence interval = 1.32–1.73, P < 0.001). In the subgroup analysis, a low BCLR was an independent risk factor for prognosis inpatients with lung (HR = 1.40, 95%CI = 1.13–1.73, P = 0.002), upper gastrointestinal (HR = 1.32, 95%CI = 1.01–1.73, P = 0.041), hepatobiliary and pancreatic (HR = 1.78, 95%CI = 1.10–2.88, P = 0.020) and colorectal cancer (HR = 2.24, 95%CI = 1.57–3.18, P < 0.001). In addition, the prognostic value of low BCLR was also confirmed in underweight, normal as well as overweight and obesity populations. Multivariate logistic regression models showed that a low BCLR was an independent risk factor associated with short-term mortality, malnutrition and cancer cachexia in older patients with cancer. Two internal validation cohorts at a ratio of 7:3 confirmed the results of our study.

conclusionThe BCLR is a promising indicator to assess nutritional-inflammatory status in older patients with cancer and can be used to identify patients with worse prognoses.

Indexed as

Body Mass IndexInflammationNeoplasmsAgedAged, 80 and overC-Reactive ProteinFemaleFollow-Up StudiesHumansMalePredictive Value of TestsPrognosisProspective StudiesC-Reactive ProteinBody mass indexCancerInflammationOlder patientsPrognosis

Identifiers

PMID41735913
PMCPMC13041399

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.